This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Inje University. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: In Seop So: Innovator in Cancer Gene Therapy
Introduction
In Seop So is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of gene therapy, particularly in targeting cancer cells. His innovative approach has the potential to revolutionize cancer treatment.
Latest Patents
In Seop So holds a patent for a cancer cell targeting gene delivery method. This inventive chimeric ligand is a fusion polypeptide that combines a single-chain antibody specific for the Tag-72 surface antigen with the GaLV envelope glycoprotein. The method demonstrates high transduction efficiency to cancer cells, specifically infecting target cells and effectively delivering therapeutic genes. This chimeric ligand can be utilized for gene therapy aimed at inhibiting tumor growth and metastasis.
Career Highlights
In Seop So is affiliated with Inje University, where he continues to advance his research in gene therapy. His work has garnered attention for its innovative approach to treating cancer, showcasing his dedication to improving patient outcomes.
Collaborations
In his research endeavors, In Seop So collaborates with notable colleagues, including Hyojeong Hong and Young-Kwan Lee. Their combined expertise contributes to the advancement of cancer treatment methodologies.
Conclusion
In Seop So's contributions to cancer gene therapy highlight his role as an innovator in the field. His patented methods offer promising avenues for future research and treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile